Strong word-of-mouth and critical acclaim from its surprise breakout opening have positioned A24’s three-hour Elizabeth Holmes documentary for robust theatrical legs through November 30. Released October 16 in 855 theaters, the Nathan Fielder–Lance Oppenheim film opened to $15.6 million—roughly double pre-release tracking—delivering the largest non-concert documentary debut in over a decade and the biggest per-screen average for a limited release since Borat. Near-universal reviews (97–99 Metacritic/RT) and 99% audience scores, plus over 2,000 sellouts and strong under-35 turnout, have driven consistent daily holds and midweek chart dominance, pushing the domestic cume past $25 million in its first week. Expansion to roughly 2,600 screens for the second weekend, with $20–25 million projections, supplies the next major catalyst. Traders see the combination of low budget, sustained cultural conversation around the Theranos saga, and proven audience appetite supporting totals clustering in the $125–175 million range by month’s end, though typical documentary drop-off patterns remain a modest risk factor.
此市場將根據《You Can See Everything》截至 2026年11月30日 的本土票房收入結算。待上映日(2026年10月16日)至 2026年11月30日 之間所有日期的數值均已定案(即非片商預估)後,將使用這部電影在 The Numbers(https://www.the-numbers.com/)頁面「Box Office」分頁中「Daily Box Office Performance」所列的數據結算此市場。 如果公布的數值恰好落在兩個級距之間,本市場將按較高的級距結算。 請注意,此市場將根據 The Numbers 在「Box Office Performance」下提供的數據結算,計算截至 2026年11月30日(含當日)的數據,不論「國內」指的是僅美國,還是美國和加拿大等地區。 如果無法確定判定來源的數據是否為最終數據,本市場將保持開放,直到 https://www.boxofficemojo.com/ 和 https://www.the-numbers.com/ 均確認其最終數據。 如果截至 2026年12月31日 下午11:59 ET 仍無最終數據,將選擇另一個可信的結算來源。
機器翻譯。如有爭議,以原文為準。